Kristine Lindell, Sarah Sheldon, Luke Kingry, Paul S. Mead, Claudia Molins, Alison F. Hinckley
{"title":"2018-2019年南方蜱虫相关皮疹病(STARI)患者的流行病学、临床特征和结局","authors":"Kristine Lindell, Sarah Sheldon, Luke Kingry, Paul S. Mead, Claudia Molins, Alison F. Hinckley","doi":"10.1016/j.diagmicrobio.2025.116928","DOIUrl":null,"url":null,"abstract":"<div><div>In this study, we describe the clinical course and outcomes for 58 patients presenting with Southern tick-associated rash illness (STARI). Using 16S sequencing, no known bacterial pathogen was detected. Although an etiologic agent remains unknown, these results do provide updated information on rash color, shape, duration, and treatment outcomes.</div></div>","PeriodicalId":11329,"journal":{"name":"Diagnostic microbiology and infectious disease","volume":"113 2","pages":"Article 116928"},"PeriodicalIF":2.1000,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Epidemiologic and clinical characteristics and outcomes of patients diagnosed with Southern Tick Associated Rash Illness (STARI) – 2018-2019\",\"authors\":\"Kristine Lindell, Sarah Sheldon, Luke Kingry, Paul S. Mead, Claudia Molins, Alison F. Hinckley\",\"doi\":\"10.1016/j.diagmicrobio.2025.116928\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>In this study, we describe the clinical course and outcomes for 58 patients presenting with Southern tick-associated rash illness (STARI). Using 16S sequencing, no known bacterial pathogen was detected. Although an etiologic agent remains unknown, these results do provide updated information on rash color, shape, duration, and treatment outcomes.</div></div>\",\"PeriodicalId\":11329,\"journal\":{\"name\":\"Diagnostic microbiology and infectious disease\",\"volume\":\"113 2\",\"pages\":\"Article 116928\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2025-06-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diagnostic microbiology and infectious disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0732889325002512\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diagnostic microbiology and infectious disease","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0732889325002512","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
Epidemiologic and clinical characteristics and outcomes of patients diagnosed with Southern Tick Associated Rash Illness (STARI) – 2018-2019
In this study, we describe the clinical course and outcomes for 58 patients presenting with Southern tick-associated rash illness (STARI). Using 16S sequencing, no known bacterial pathogen was detected. Although an etiologic agent remains unknown, these results do provide updated information on rash color, shape, duration, and treatment outcomes.
期刊介绍:
Diagnostic Microbiology and Infectious Disease keeps you informed of the latest developments in clinical microbiology and the diagnosis and treatment of infectious diseases. Packed with rigorously peer-reviewed articles and studies in bacteriology, immunology, immunoserology, infectious diseases, mycology, parasitology, and virology, the journal examines new procedures, unusual cases, controversial issues, and important new literature. Diagnostic Microbiology and Infectious Disease distinguished independent editorial board, consisting of experts from many medical specialties, ensures you extensive and authoritative coverage.